2,734 Shares in Cigna Group $CI Acquired by Fox Run Management L.L.C.

Fox Run Management L.L.C. acquired a new stake in Cigna Group (NYSE:CI) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,734 shares of the health services provider’s stock, valued at approximately $904,000.

A number of other institutional investors also recently modified their holdings of the company. Brighton Jones LLC raised its holdings in Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares during the last quarter. Leavell Investment Management Inc. increased its position in shares of Cigna Group by 5.3% during the first quarter. Leavell Investment Management Inc. now owns 919 shares of the health services provider’s stock worth $302,000 after acquiring an additional 46 shares in the last quarter. Allworth Financial LP raised its holdings in shares of Cigna Group by 4.1% in the 1st quarter. Allworth Financial LP now owns 6,344 shares of the health services provider’s stock worth $2,130,000 after acquiring an additional 247 shares during the last quarter. Cerity Partners LLC lifted its position in Cigna Group by 1.0% in the 1st quarter. Cerity Partners LLC now owns 94,146 shares of the health services provider’s stock valued at $30,974,000 after acquiring an additional 916 shares in the last quarter. Finally, Ballentine Partners LLC boosted its stake in Cigna Group by 21.0% during the 1st quarter. Ballentine Partners LLC now owns 7,966 shares of the health services provider’s stock valued at $2,621,000 after purchasing an additional 1,383 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on CI shares. Cantor Fitzgerald dropped their target price on Cigna Group from $365.00 to $325.00 in a report on Friday, October 31st. Guggenheim dropped their price objective on Cigna Group from $350.00 to $309.00 in a research note on Friday, October 31st. TD Cowen reduced their target price on shares of Cigna Group from $387.00 to $333.00 and set a “buy” rating for the company in a research note on Tuesday, November 4th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Cigna Group in a report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. cut their price target on shares of Cigna Group from $428.00 to $375.00 and set an “overweight” rating on the stock in a report on Tuesday, November 4th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $339.73.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares of the company’s stock, valued at $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider owned 51,182 shares of the company’s stock, valued at $15,354,600. This represents a 9.49% decrease in their position. The SEC filing for this sale provides additional information. 0.70% of the stock is owned by corporate insiders.

Cigna Group Stock Up 3.2%

Cigna Group stock opened at $264.54 on Monday. The firm has a 50 day moving average price of $293.24 and a 200-day moving average price of $303.30. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The company has a market capitalization of $70.66 billion, a P/E ratio of 14.44, a P/E/G ratio of 0.88 and a beta of 0.44.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same quarter in the previous year, the firm posted $7.51 EPS. Cigna Group’s revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s dividend payout ratio is currently 26.64%.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.